Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Kerr

Showing results (21-30 of 106) with videos related to

Pageof 11
Sort By:
Heart, Lung & Circulation|May 20, 2020
Target Doses of Secondary Prevention Medications Are Not Being Achieved in Patients With Reduced Left Ventricular Ejection Fraction After Acute Coronary Syndrome (ANZACS-QI 34)Daniel Chan, Robert N Doughty, Mayanna Lund, et al.
Heart, Lung & Circulation|July 1, 2019
Prescribing Performance Post-Acute Coronary Syndrome Using a Composite Medication Indicator: ANZACS-QI 24Chethan Kasargod, Gerry Devlin, Mildred Lee, et al.
International Journal of Epidemiology|July 17, 2018
Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New ZealandersSuneela Mehta, Rod Jackson, Romana Pylypchuk, et al.
The New Zealand Medical Journal|December 24, 2013
Risk stratification and timing of coronary angiography in acute coronary syndromes: are we targeting the right patients in a timely manner? (ANZACS-QI 1)Andrew J Kerr, Aaron Lin, Mildred Lee, et al.
The New Zealand Medical Journal|June 30, 2016
Dispensing data captures individual-level use of aspirin for cardiovascular disease prevention, despite availability over-the-counterVanessa Selak, Yulong Gu, Natasha Rafter, et al.
Australian and New Zealand Journal of Public Health|June 4, 2014
Twenty-eight day and one-year case fatality after hospitalisation with an acute coronary syndrome: a nationwide data linkage studyCorina Grey, Rod Jackson, Susan Wells, et al.
Heart, Lung & Circulation|January 13, 2012
Clinical characteristics and outcome of apical ballooning syndrome in Auckland, New ZealandJen-Li Looi, Chi-Wing Wong, Ali Khan, et al.
European Journal of Preventive Cardiology|June 30, 2016
Ethnic differences in case fatality following an acute ischaemic heart disease event in New Zealand: ANZACS-QI 13Corina Grey, Rod Jackson, Susan Wells, et al.
Heart, Lung & Circulation|March 7, 2024
Cardiogenic Shock Prior to Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: Outcomes and Predictors of Mortality (ANZACS-QI 73)Kyu Hyun Lee, Wil Harrison, Kok Lam Chow, et al.
Heart, Lung & Circulation|May 24, 2011
Comparison of atrial and brain natriuretic peptide for the assessment of mitral stenosisVishal Sharma, Ralph A H Stewart, Irene Zeng, et al.
Pageof 11

Showing results (21-30 of 106) with videos related to

Sort By:
Pageof 11
Heart, Lung & Circulation|May 20, 2020
Target Doses of Secondary Prevention Medications Are Not Being Achieved in Patients With Reduced Left Ventricular Ejection Fraction After Acute Coronary Syndrome (ANZACS-QI 34)Daniel Chan, Robert N Doughty, Mayanna Lund, et al.
Heart, Lung & Circulation|July 1, 2019
Prescribing Performance Post-Acute Coronary Syndrome Using a Composite Medication Indicator: ANZACS-QI 24Chethan Kasargod, Gerry Devlin, Mildred Lee, et al.
International Journal of Epidemiology|July 17, 2018
Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New ZealandersSuneela Mehta, Rod Jackson, Romana Pylypchuk, et al.
The New Zealand Medical Journal|December 24, 2013
Risk stratification and timing of coronary angiography in acute coronary syndromes: are we targeting the right patients in a timely manner? (ANZACS-QI 1)Andrew J Kerr, Aaron Lin, Mildred Lee, et al.
The New Zealand Medical Journal|June 30, 2016
Dispensing data captures individual-level use of aspirin for cardiovascular disease prevention, despite availability over-the-counterVanessa Selak, Yulong Gu, Natasha Rafter, et al.
Australian and New Zealand Journal of Public Health|June 4, 2014
Twenty-eight day and one-year case fatality after hospitalisation with an acute coronary syndrome: a nationwide data linkage studyCorina Grey, Rod Jackson, Susan Wells, et al.
Heart, Lung & Circulation|January 13, 2012
Clinical characteristics and outcome of apical ballooning syndrome in Auckland, New ZealandJen-Li Looi, Chi-Wing Wong, Ali Khan, et al.
European Journal of Preventive Cardiology|June 30, 2016
Ethnic differences in case fatality following an acute ischaemic heart disease event in New Zealand: ANZACS-QI 13Corina Grey, Rod Jackson, Susan Wells, et al.
Heart, Lung & Circulation|March 7, 2024
Cardiogenic Shock Prior to Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: Outcomes and Predictors of Mortality (ANZACS-QI 73)Kyu Hyun Lee, Wil Harrison, Kok Lam Chow, et al.
Heart, Lung & Circulation|May 24, 2011
Comparison of atrial and brain natriuretic peptide for the assessment of mitral stenosisVishal Sharma, Ralph A H Stewart, Irene Zeng, et al.
Pageof 11